LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 62 filers reported holding LYRA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $769,298 | -95.6% | 2,780,261 | 0.0% | 0.16% | -94.0% |
| Q1 2024 | $17,293,223 | +18.7% | 2,780,261 | 0.0% | 2.68% | +18.0% |
| Q4 2023 | $14,568,568 | +34.0% | 2,780,261 | 0.0% | 2.27% | -31.9% |
| Q3 2023 | $10,870,821 | -4.9% | 2,780,261 | 0.0% | 3.33% | +65.9% |
| Q2 2023 | $11,426,873 | +219.9% | 2,780,261 | +56.4% | 2.01% | +171.8% |
| Q1 2023 | $3,572,275 | -36.0% | 1,777,251 | 0.0% | 0.74% | -38.6% |
| Q4 2022 | $5,580,568 | -37.3% | 1,777,251 | 0.0% | 1.20% | -42.1% |
| Q3 2022 | $8,904,000 | -11.3% | 1,777,251 | 0.0% | 2.08% | -22.5% |
| Q2 2022 | $10,041,000 | – | 1,777,251 | – | 2.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,222,560 | $12,955,000 | 0.26% |
| Ikarian Capital, LLC | 422,338 | $1,698,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 520,544 | $2,093,000 | 0.07% |
| Clearline Capital LP | 119,924 | $482,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 66,900 | $269,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,516 | $155,000 | 0.00% |
| Pentwater Capital Management LP | 60,000 | $241,000 | 0.00% |
| Worth Asset Management, LLC | 650 | $3,000 | 0.00% |
| Close Asset Management Ltd | 7,000 | $30,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $2,000 | 0.00% |